Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CACVANALSTINE, Melissa A; WENTLAND, Mark P; COHEN, Dana J et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 23, pp 6516-6520, issn 0960-894X, 5 p.Article

Syntheses and opioid receptor binding properties of carboxamido-substituted opioidsWENTLAND, Mark P; RONGLIANG LOU; QUN LU et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 1, pp 203-208, issn 0960-894X, 6 p.Article

Central antinociception induced by μ-opioid receptor agonist morphine, but not δ- or κ-, is mediated by cannabinoid CB₁ receptorDA FONSECA PACHECO, Daniela; KLEIN, André; CASTRO PEREZ, Andréa et al.British journal of pharmacology. 2009, Vol 158, Num 1, pp 225-231, issn 0007-1188, 7 p.Article

High-performance liquid chromatographic enantioseparation of methanobenzazocinesBARKER, William M; WORM, Karin; DOLLE, Roland E et al.Journal of chromatography. 2009, Vol 1216, Num 45, pp 7708-7714, issn 0021-9673, 7 p.Article

Identification of the three-dimensional pharmacophore of κ-opioid receptor agonistsYAMAOTSU, Noriyuki; FUJII, Hideaki; NAGASE, Hiroshi et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 12, pp 4446-4452, issn 0968-0896, 7 p.Article

Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R, 5R, 9R)-5, 9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082)ACETO, Mario D; MAY, Everette L; HARRIS, Louis S et al.European journal of pharmacology. 2007, Vol 566, Num 1-3, pp 88-93, issn 0014-2999, 6 p.Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethylcarboxamido] analogues of cyclazocine and ethylketocycalzocineWENTLAND, Mark P; VANALSTINE, Melissa; KUCEJKO, Robert et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 18, pp 5635-5639, issn 0022-2623, 5 p.Article

Novel rearrangement reaction of a 6,14-endoethanomorphinan derivative to a benzomorphan derivativeFUJII, Hideaki; WATANABE, Yoshikazu; OSA, Yumiko et al.Tetrahedron (Oxford. Print). 2009, Vol 65, Num 25, issn 0040-4020, 4782, 4808-4813 [7 p.]Article

The μ-opioid receptor agonist morphine, but not agonists at 6-or K-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptorsDA FONSECA PACHECO, D; KLEIN, A; DE CASTRO PEREZ, A et al.British journal of pharmacology. 2008, Vol 154, Num 5, pp 1143-1149, issn 0007-1188, 7 p.Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: Syntheses and opioid receptor properties of cyclic variants of cyclazocineWENTLAND, Mark P; QUN LU; GANORKAR, Rakesh et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 2, pp 365-368, issn 0960-894X, 4 p.Article

Combination of Virtual Screening and High Throughput Gene Profiling for Identification of Novel Liver X Receptor ModulatorsCHENG, Jie-Fei; ZAPF, James; KUI XU et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 7, pp 2057-2061, issn 0022-2623, 5 p.Article

The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: BenzomorphansMETCALF, Matthew D; ACETO, Mario D; HARRIS, Louis S et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 2, pp 869-873, issn 0968-0896, 5 p.Article

Evaluation of N-substitution in 6,7-benzomorphan compoundsPASQUINUCCI, Lorella; PREZZAVENTO, Orazio; RONSISVALLE, Giuseppe et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 14, pp 4975-4982, issn 0968-0896, 8 p.Article